Schonfeld Strategic Advisors LLC Innoviva, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 62,903 shares of INVA stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

62,903

Holding current value

$1.26 Million

% of portfolio

0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $905,803 - $1.03 Million	62,903 New	62,903 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $584,189 - $771,490	47,418 New	47,418 $760,000
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $527,433 - $668,508	-49,155 Reduced 58.19%	35,313 $397,000
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $739,093 - $863,110	-62,635 Reduced 42.58%	84,468 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $1.71 Million - $2.24 Million	147,103 New	147,103 $1.71 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $531,272 - $737,548	-37,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $570,969 - $751,275	37,100 New	37,100 $718,000
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $150,862 - $283,308	-18,602 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $191,228 - $267,496	18,602 New	18,602 $264,000
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $691,736 - $796,790	-50,751 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $682,093 - $892,710	50,751 New	50,751 $700,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $1.06 Million - $1.3 Million	-76,780 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $354,656 - $445,966	-30,235 Reduced 28.25%	76,780 $1.09 Million
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $1.29 Million - $1.51 Million	107,015	107,015 $1.51 Million

Others Institutions Holding INVA

# of Institutions

220

Shares Held

79.5M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.39B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Innoviva, Inc. Transaction History